Engager T Cells: A Novel Immunotherapeutic for AML |
University of Michigan / Challice Bonifant, MD, PhD |
Young Investigator Grants |
2015 |
Michigan |
Targeted Hyperactivation of PI3K/AKT in B-cell malignancies |
Dana-Farber Cancer Institute / Vishal Khairnar, PhD |
Young Investigator Grants |
2019 |
Massachusetts |
Novel Synergistic Targets for Combination Therapy in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Yang Ding, MD |
Young Investigator Grants |
2020 |
Pennsylvania |
Identification of Mechanisms of Resistance to Trametinib Monotherapy in PAX-fusion Negative Rhabdomyosarcoma |
National Cancer Institute / Marielle Yohe, MD/PhD |
Young Investigator Grants |
2016 |
Maryland |
Investigation of Oncogenic Long Non-coding RNAs in Ewing sarcoma |
Lucile Packard Children’s Hospital at Stanford University School of Medicine / Siu Ping Ngok, PhD |
Young Investigator Grants |
2014 |
California |
Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct |
University of Wisconsin - Madison / Mario Otto |
Young Investigator Grants |
2012 |
Wisconsin |
The Cebpa Downstream Enhancer as a Key Target of Transformation to Acute Myeloid Leukemia |
The Johns Hopkins University School of Medicine / Stacy Cooper, MD |
Young Investigator Grants |
2015 |
Maryland |
A CRISPRi Genetic Screen in Ewing sarcoma Identifies a Novel Dependence on Homologous Recombination DNA Repair |
University of California San Francisco / Asmin Tulpule, MD/PhD |
Young Investigator Grants |
2016 |
California |
Treatment for human hepatoblastoma based on recombinant adeno-associated virus vectors |
University of Florida / Chen Ling |
Young Investigator Grants |
2012 |
Florida |
Mechanisms of regulation of the PI#K/AKT pathway downstream of NOTCH1 in T-ALL.
|
Columbia University / Teresa Palomero, PhD |
Young Investigator Grants |
2007 |
New York |